The Federal Deposit Insurance Corporation (FDIC) has approved a proposal to roll back a Biden-era policy that increased scrutiny on large bank mergers. The decision, announced Monday, reinstates the pre-2024 merger policy while the agency reassesses its review process.
This move, led by the Republican-controlled FDIC, reverses stricter regulations imposed by the previous Democratic leadership, which aimed to heighten oversight of mergers involving large financial institutions. The 2024 policy required public hearings for bank mergers resulting in assets exceeding $50 billion and mandated heightened financial stability reviews for those surpassing $100 billion.
The rollback aligns with a broader shift under the pro-business Trump administration, which contrasts with Biden-era policies that pushed for tougher regulatory scrutiny on corporate mergers. Banks have long criticized the merger approval process as overly complex and opaque. The Bank Policy Institute, representing large financial firms, opposed the 2024 policy, arguing it created regulatory uncertainty and exceeded Congress’s intended oversight.
By reverting to the prior framework, the FDIC aims to provide a more predictable path for bank mergers while conducting a comprehensive evaluation of its policies.


Trump Orders Warning Signs Outside Smithsonian Museum Over ‘Anti-American’ Exhibits
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers
Lebanon Lawyers Seek Probe Into Banker Over Alleged Netanyahu Dinner in Washington
EEOC Drops Penn Subpoena in Antisemitism Probe, Investigation Continues
California ICE Detention Center Found to Have Inadequate Medical Care, Court Monitor Says
China Vows Retaliation Over U.S. Ban on Chinese Robots, Power Inverters
Iran Warns of Retaliation as Trump Threatens New Strikes, Oil Risks Intensify
Spain Deploys Troops as Ceuta Faces Major Migrant Surge From Morocco
Trump Administration Weighs Ending Support for UN Refugee Agency UNHCR
North Korea Warns U.S. Forces Japan Expansion Raises Korea Conflict Risk
Trump Announces 100% Tariff on Generic Drug Imports Starting in 2028
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise
Trump Administration Imposes New Forced Labor Tariffs on 60 Trading Partners
Trump-Backed Russia Sanctions Bill Faces House Hurdles Over Tariff Powers
Trump Says U.S. ICC Campaign Aims to Protect Netanyahu, Not Himself
Trump Administration Monitors OpenAI Incident as Lawmakers Push AI Kill Switch Bill 



